Perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics

Michael Hughes, Shelton Caruthers, Trung Tran, Jon Marsh, Kirk Wallace, Tillman Cyrus, Kathryn Partlow, Michael Scott, Michal Lijowski, Anne Neubauer, Patrick Winter, Grace Hu, Hyuing Zhang, John McCarthy, Brian Maurizi, John Allen, Cordellia Caradine, Robert Neumann, Jeffrey Arbeit, Gregory LanzaSamuel Wickline

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Molecular imaging is a novel tool that has allowed noninvasive diagnostic imaging to transition from gross anatomical description to identification of specific tissue epitopes and observation of biological processes at the cellular level. Until recently, this technique was confined to the field of nuclear imaging; however, advances in nanotechnology have extended this research to include magnetic resonance (MR) imaging, positron emission tomography (PET), single photon emission computed tomography (SPECT), and ultrasound (US), among others. The application of nanotechnology to MR, SPECT, and US molecular imaging has generated several candidate contrast agents. We discuss the application of one multimodality platform, a targeted perfluorocarbon nanoparticle. Our results show that it is useful for noninvasive detection with all three imaging modalities and may additionally be used for local drug delivery.

Original languageEnglish
Article number4446657
Pages (from-to)397-415
Number of pages19
JournalProceedings of the IEEE
Issue number3
StatePublished - Mar 2008


  • Contrast agent
  • Multiplatform contrast agent
  • Targeted contrast
  • Tumor imaging


Dive into the research topics of 'Perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics'. Together they form a unique fingerprint.

Cite this